SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Official Melania Meme (MELANIA) is a cryptocurrency and operates on the Solana platform. Official Melania Meme has a current supply of 999,995,392.634966 with 999,995,392.634962 in circulation. The last known price of Official Melania Meme is 0.04540986 USD and is down -12.94 over the last 24 hours. It is currently trading on 310 active market(s) with $4,518,778.32 traded over the last 24 hours. More information can be found at https://melaniameme.com/.

Melania Trump

MELANIA is drawing attention over its steep decline and its status as a Trump-family meme coin, with many traders calling it a speculative cash grab and questioning its utility. A smaller group is discussing buying the dip or expecting a rebound, but the conversation is predominantly bearish and focused on losses and scam concerns.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor is drawing attention ahead of the FDAs November 22 decision on deramiocel for Duchenne muscular dystrophy, with discussion focused on whether the agency will accept the companys evidence for an upper-limb indication despite concerns about the trials statistical analysis. Traders are split between expecting approval and a potential short squeeze versus fearing a rejection or delay, making the upcoming decision a high-stakes binary catalyst.

Devon Energy Corp. engages in the exploration, development, and production of oil and natural gas properties. It develops and operates Delaware Basin, Eagle Ford, Heavy Oil, Barnett Shale, STACK, and Rockies Oil. The company was founded by J. Larry Nichols and John W. Nichols in 1971 and is headquartered in Oklahoma City, OK.

Devon Energy Corp.

Devons quarterly results and sharp share-price decline are driving discussion: despite reports of an earnings beat and strong production, traders are frustrated by the selloff and debate whether oil-price weakness, concerns about debt and hedging, or an analyst downgrade explain it. Some view the drop as an overreaction and point to buybacks and cash flow, while others remain cautious about the stocks performance.

Avalanche (AVAX) is a cryptocurrency launched in 2020. Avalanche has a current supply of 471,438,169.1160568 with 446,436,169.1160568 in circulation. The last known price of Avalanche is 6.99518175 USD and is down -15.00 over the last 24 hours. It is currently trading on 1135 active market(s) with $402,139,637.32 traded over the last 24 hours. More information can be found at https://avax.network/.

Avalanche

AVAX is drawing attention amid a sharp selloff, with traders frequently saying it is following Bitcoin lower while falling harder than many other altcoins. Some point to institutional tokenization developments, including the NYSE-related news, but debate whether those headlines create meaningful value for the token as price gains have repeatedly faded.

iShares Trust - iShares Biotechnology ETF

iShares Biotechnology ETF

IBB is drawing attention as biotech consolidates amid mixed sector sentiment; traders describe the ETF as holding up better than smaller-cap biotech, while debating whether recent pullbacks are routine pauses or renewed weakness. Discussion also tracks sector-wide clinical and regulatory catalysts, but no single event dominates.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

Golds sharp pullback is being tied to hotter inflation data and increased expectations for Fed rate hikes, which have lifted Treasury yields and the dollar. Traders are divided between expecting further losses and treating the selloff as a buying opportunity, with some long-term holders still viewing gold as a hedge.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit is drawing attention around the FDA decision on ivonescimab for EGFR-mutated lung cancer, with traders watching for an approval, a complete response letter, or a delay. The debate centers on strong progression-free-survival results and improving overall-survival data versus the FDAs stated need for statistically significant overall-survival evidence; the share-price decline has heightened uncertainty rather than resolved it.

Dogecoin (DOGE) is a cryptocurrency . Users are able to generate DOGE through the process of mining. Dogecoin has a current supply of 156,752,062,860.16806072. The last known price of Dogecoin is 0.05689686 USD and is down -11.89 over the last 24 hours. It is currently trading on 1545 active market(s) with $1,128,721,930.78 traded over the last 24 hours. More information can be found at http://dogecoin.com/.

Dogecoin

Dogecoin is drawing attention amid a sharp crypto selloff and a decline toward multi-year lows. Traders are split between calling the drop a buying opportunity and warning that further losses may follow, with many expressing frustration over the prolonged downtrend.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Bitcoins sharp, volatile swings are drawing attention, with traders pointing to leveraged liquidations, spot ETF outflows, and broader risk-off pressure tied to rates and tech weakness. The community is split between dip-buyers expecting a rebound and bears warning that selling could continue.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Taus REGAIN trial update in recurrent glioblastoma at SNO is driving attention, with traders reacting positively to striking early response data and an upcoming management call to discuss the results. Some caution that the findings come from a small interim cohort and that durability and results from the expanded trial remain important to assess.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

About APWR